Strategic Director, Dissolution Science & Biopharmaceutics

100 Eli Lilly and Company; Indianapolis (IN); On-site; USD 149,000 - 257,000; Full time

Benefits offered by this job

401(k) plan

Well-being benefits

Job summary

Lilly in Indianapolis, IN is seeking a Director/Senior Director/Executive Director to lead the dissolution science and biopharmaceutics function for small molecule drug products, from early development through commercialization.

You will manage a small team (1–5 scientists), drive product performance strategies, author regulatory content for global submissions, and collaborate with formulation, analytical, engineering, ADME, clinical pharmacology, and regulatory colleagues to advance programs.

Qualifications

• Ph.D. in Pharmaceutical Sciences or related field with extensive industry experience.
• Proven leadership in dissolution science and biopharmaceutics for small molecules.
• Experience authoring regulatory submissions and responses across global markets.
• Strong collaboration across formulation, analytical, engineering, and regulatory teams.

Responsibilities

• Develop and justify dissolution methods linking in vitro and in vivo performance.
• Lead biopharmaceutics strategies using in vitro/in vivo/in silico tools including PBBM.
• Support cross-functional teams and oversight of multiple projects.

Skills

Dissolution science

Biopharmaceutics

Regulatory guidance

Leadership

PBBM

Education

Ph.D. in Pharmaceutical Sciences

M.S. in related field

B.S. in related field

Tools

GastroPlus

Simcyp

DDDPlus

STELLA

Job description

Lilly in Indianapolis, IN is seeking a Director/Senior Director/Executive Director to lead the dissolution science and biopharmaceutics function for small molecule drug products, from early development through commercialization.

You will manage a small team (1–5 scientists), drive product performance strategies, author regulatory content for global submissions, and collaborate with formulation, analytical, engineering, ADME, clinical pharmacology, and regulatory colleagues to advance programs.